Bioengineering strategies to accelerate stem cell therapeutics.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29769665.
- Also identified by DOI 10.1038/s41586-018-0089-z and PMC identifier 6773426.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although only a few stem cell-based therapies are currently available to patients, stem cells hold tremendous regenerative potential, and several exciting clinical applications are on the horizon. Biomaterials with tuneable mechanical and biochemical properties can preserve stem cell function in culture, enhance survival of transplanted cells and guide tissue regeneration. Rapid progress with three-dimensional hydrogel culture platforms provides the opportunity to grow patient-specific organoids, and has led to the discovery of drugs that stimulate endogenous tissue-specific stem cells and enabled screens for drugs to treat disease. Therefore, bioengineering technologies are poised to overcome current bottlenecks and revolutionize the field of regenerative medicine.
Medical subject headings
- Bioengineering
- Regenerative Medicine
- Stem Cell Transplantation
- Stem Cells